MARY WALL: Open Payments
NPI 1134689920 · DRESDEN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$282 in 10 payments from 8 companies in 2025. Trend: 2023 $199 · 2024 $1,990 · 2025 $282
Food & beverage: $282
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $125 |
| Viatris Specialty LLC | 2 | $31 |
| Lundbeck LLC | 2 | $31 |
| Braeburn Inc. | 1 | $26 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
| ABBVIE INC. | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $14 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
Products named: CAPLYTA, REXULTI, YUPELRI, BRIXADI, HETLIOZ, QULIPTA, Auvelity.
Industry payments across TN — which companies pay providers there.
